Atlas Trials

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis

Clinical trial NCT01373710 · COMPLETED

Trial details

NCT number
NCT01373710
Sponsor
Institut Curie
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Breast CancerCarcinomatous Meningitis
Start date
2011-05-19
Primary completion
2018-04-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.